Contact Us

LCTC Post Trial Tissue Bank - Access to Samples

Criteria for Access

Full review and scientific critique of each application for collection access will be undertaken by the LCTC Post-Trial Tissue Bank Oversight Committee and the appropriate tumour group sub-committee. The following overarching criteria must be met to access samples in this collection:

  1. Research to be undertaken must be scientifically sound.
  2. The proposed project must be within the fields of medical or biomedical research.
  3. Requestors must be affiliated to a recognised academic institution or NHS organisation; or of a commercial research organisation with experience in cancer research.
  4. Research must comply with the terms indicated in the documented initial donor consent.
  5. Requestors should be able to demonstrate, through their peer reviewed publications in the area proposed research area, their ability to carry out the proposed study.
  6. Intended storage, use and disposal of sample material must be in accordance with the Human Tissue Authority Standards and Codes of Practice.
  7. Research must be fully funded with a realistic timeline for completion of sample use.
  8. Researchers conducting studies on data or samples from the LCTC Post-Trial Tissue Bank must have approval from the appropriate Research Ethics Committee (REC) before being granted full access.

Prioritisation of access to the collection will be based on scientific merit as judged by the Oversight Committee and sub-committee and cancer research in the relevant speciality.

More details on limitation on the use of the collection, along with details on fees, can be found in the access policy.

Limitations on use of the Collection

Applications are welcome for studies in all areas but, where samples are limited, priority will be given to research directly related to the original purpose of collection i.e. cancer research in the relevant speciality.

The collection does not have documented consent by the donor for use of identifiable samples in research. Samples and data will not be released if they do not fall under the scope of the documented consent of donors.

Samples will not be transferred outside of the European Economic Area (EAA) or used for genetic studies without explicit consent.

Samples cannot be used in research into termination of pregnancy or reproductive cloning.

Samples cannot be provided with identifiable information.


How to apply

The process from initial contact to sample release is described in this flowchart.

If you would like to access the collection the first stage is to contact the custodian via e-mail, giving a brief outline of the proposed study, methodology and number and type of samples required. The custodian will assess the suitability of the application and respond to the applicant. Following discussions with the custodian, access to the application form will be provided.

Further Information

Please click links below for further information: